INVESCO Ltd (IVZ)

31.64
+0.28 (0.89%)
NYSE· Last Trade: Aug 12th, 3:00 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Better Healthcare ETF: State Street's Pharmaceuticals-Focused XPH vs. Invesco's S&P 500-Targeted RSPHfool.com
One fund targets pharma exclusively and surged 63% in a year, while the other diversifies across healthcare with lower volatility.
Via The Motley Fool · August 12, 2026
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style?fool.com
VanEck targets established pharma giants with lower costs and volatility, while Invesco pursues high-growth biotech companies. One delivered stronger returns; the other weathered downturns better.
Via The Motley Fool · August 12, 2026
Which Banking ETF Is the Better Buy: iShares' European EUFN or Invesco's U.S.-Focused KBWB?fool.com
EUFN provides broader geographic diversification across developed Europe with lower volatility, while KBWB concentrates on U.S. banks for more concentrated exposure.
Via The Motley Fool · August 11, 2026
Which Is the Better Energy Sector ETF, the AMLP's Focus on Traditional Energy or Invesco's TAN Targeting Solar?fool.com
AMLP offers a 7% dividend yield and lower volatility, while TAN delivers higher growth potential and 41% one-year returns.
Via The Motley Fool · August 11, 2026
Which Consumer Staples ETF Is Better, Fidelity's FSTA or Invesco's PBJ?fool.com
Fidelity's broader 104-stock portfolio and lower 0.08% expense ratio deliver superior returns and a 2.2% dividend yield.
Via The Motley Fool · August 11, 2026
Is iShares US Consumer Staples ETF a Better Buy Than Invesco Food & Beverage?fool.com
iShares U.S. Consumer Staples offers broader diversification with 53 holdings versus PBJ's 31, plus a lower 0.38% expense ratio and higher 2.6% dividend yield for income investors.
Via The Motley Fool · August 11, 2026
QUICK SPARK: Nasdaq 100 Breadth Hits Its Strongest Level in Over a Yearbenzinga.com
Nasdaq 100 breadth reaches 1-year high, with 70% of Invesco QQQ Trust stocks trading above 200-day moving average. ETF inflows favor SPY & QQQ.
Via Benzinga · August 10, 2026
Why These 3 Equal Weight ETFs Have Outperformed the S&P This Yearmarketbeat.com
Equal-weight ETFs like ROE, RSPT, and AIVC have outperformed market-cap-weighted benchmarks in 2026 by diversifying holdings and reducing reliance on a handful of mega-cap stocks.
Via MarketBeat · August 8, 2026
Invesco Mortgage Capital (IVR) Q2 2026 Earnings Call Transcriptfool.com
CEO Collins discusses ATM equity program and portfolio expansion.
Via The Motley Fool · August 7, 2026
Which Growth ETF Is the Better Long-Term Buy: Vanguard's Mega Cap MGK or Invesco's Small-Cap RZG?fool.com
Vanguard's tech-heavy portfolio delivered stronger five-year returns despite higher volatility, while Invesco's small-cap approach offers broader sector diversification.
Via The Motley Fool · August 7, 2026
Tech Stocks Under Pressure: 1 Magnificent ETF to Buy on the Dipfool.com
The share prices of even the most valuable businesses can be highly volatile during earnings season.
Via The Motley Fool · August 7, 2026
History Says Investing $400 per Month in This ETF Could Set You Up for Life. Here's How.fool.com
Investing in the Invesco QQQ ETF could put you on the path to a $1 million portfolio, if you can ride out the volatility.
Via The Motley Fool · August 6, 2026
If a Stock Market Crash Is Coming, I'm Loading Up on This ETF Without a Second Thoughtfool.com
Even if there's a stock market downturn, I believe this Vanguard ETF is almost always a good buy.
Via The Motley Fool · August 4, 2026
History Says Investors Who Built the Most Wealth All Have This 1 Thing in Commonfool.com
Recognizing what you can and can't predict with any reliable consistency forces you to use an approach with clearer, higher odds.
Via The Motley Fool · August 4, 2026
2 Unstoppable Growth ETFs Worth Buying and Holding Through Every Market Cyclefool.com
Both ETFs have stood the test of time and track world-class companies.
Via The Motley Fool · August 4, 2026
If You Invested $1000 In Invesco S&P 500 Momentum ETF Stock 5 Years Ago, You Would Have This Much Todaybenzinga.com
Invesco S&P 500 Momentum ETF (NYSE:SPMO) has outperformed the market over the past 5 years by 7.87% on an annualized basis producing an average annual return of 19.44%. Currently, Invesco S&P 500 Momentum ETF
Via Benzinga · August 4, 2026
3 Magnificent ETFs I'm Buying Hand Over Fist in 2026fool.com
They all complement each other well, covering a lot of ground for investors.
Via The Motley Fool · August 4, 2026
5 Revealing Analyst Questions From Invesco’s Q2 Earnings Call
Invesco’s second quarter results saw the company surpass analysts’ expectations for both revenue and adjusted earnings per share. Management attributed the q...
Via StockStory · August 4, 2026
Is QQQ Worth Buying Now That SpaceX Has Joined the Nasdaq-100? Here's My Honest Take.fool.com
SpaceX may be getting a lot of media attention, but it has a relatively small impact on the Nasdaq-100 at the moment.
Via The Motley Fool · August 3, 2026
The Nasdaq Recently Hit Correction Territory. Here's What History Says Comes Next.fool.com
Corrections are a normal part of investing in stocks. But the market is still very likely to thrive over time.
Via The Motley Fool · August 3, 2026
If I Were in My 20s, I'd Buy This Magnificent ETF and Hold It Until Retirementfool.com
Young investors can build significant wealth in the stock market by focusing on the long term.
Via The Motley Fool · August 2, 2026
3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Storymarketbeat.com
BBHY, BKLN, and JAAA offer different fixed-income strategies, with yields ranging from 4.95% to 7.79%, varying fees, and differing credit quality and recession exposure.
Via MarketBeat · August 2, 2026
1 Thing Every Investor Needs to Know About Buying the S&P 500 Right Nowfool.com
The index encompasses 500 big companies, but some are far more influential than others.
Via The Motley Fool · August 2, 2026
XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?fool.com
IBBQ posted the stronger return over the past year, but has also experienced much higher historical volatility than XLV.
Via The Motley Fool · August 1, 2026
XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?fool.com
PBE surged 41% in one year but endured a 35% drawdown, while XLV's diversified approach delivered steadier gains with half the volatility.
Via The Motley Fool · August 1, 2026